Home
About
Overview
Sharing Data
ORCID
Help
History (1)
VAV3 mediates resistance to breast cancer endocrine therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
VAV3 mediates resistance to breast cancer endocrine therapy.
VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014 May 28; 16(3):R53.
View in:
PubMed
subject areas
Androstadienes
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Biomarkers, Tumor
Breast
Breast Neoplasms
Cell Line, Tumor
Cell Proliferation
Cell Survival
Drug Resistance, Neoplasm
Enzyme Activators
ErbB Receptors
Erlotinib Hydrochloride
Estrogen Receptor alpha
Female
Gene Expression Regulation, Neoplastic
Genetic Association Studies
Genetic Variation
Humans
Indazoles
MCF-7 Cells
Nitriles
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-vav
Quinazolines
RNA Interference
RNA, Small Interfering
Tamoxifen
Toremifene
Triazoles
authors with profiles
Yusuke Nakamura